Bright Green (BGXX) Competitors $0.06 -0.01 (-15.35%) (As of 05:33 PM ET) Add Compare Share Share Competitors Stock AnalysisChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrends BGXX vs. CRVO, CNTB, SPRO, AADI, XCUR, CASI, STTK, ALVR, IOBT, and PRLDShould you be buying Bright Green stock or one of its competitors? The main competitors of Bright Green include CervoMed (CRVO), Connect Biopharma (CNTB), Spero Therapeutics (SPRO), Aadi Bioscience (AADI), Exicure (XCUR), CASI Pharmaceuticals (CASI), Shattuck Labs (STTK), AlloVir (ALVR), IO Biotech (IOBT), and Prelude Therapeutics (PRLD). These companies are all part of the "pharmaceutical products" industry. Bright Green vs. CervoMed Connect Biopharma Spero Therapeutics Aadi Bioscience Exicure CASI Pharmaceuticals Shattuck Labs AlloVir IO Biotech Prelude Therapeutics CervoMed (NASDAQ:CRVO) and Bright Green (NASDAQ:BGXX) are both small-cap medical companies, but which is the better stock? We will compare the two businesses based on the strength of their analyst recommendations, community ranking, profitability, earnings, dividends, media sentiment, valuation, risk and institutional ownership. Does the MarketBeat Community believe in CRVO or BGXX? CervoMed received 13 more outperform votes than Bright Green when rated by MarketBeat users. CompanyUnderperformOutperformCervoMedOutperform Votes1372.22% Underperform Votes527.78% Bright GreenN/AN/A Does the media prefer CRVO or BGXX? In the previous week, CervoMed had 16 more articles in the media than Bright Green. MarketBeat recorded 16 mentions for CervoMed and 0 mentions for Bright Green. CervoMed's average media sentiment score of 0.06 beat Bright Green's score of 0.00 indicating that CervoMed is being referred to more favorably in the media. Company Overall Sentiment CervoMed Neutral Bright Green Neutral Which has stronger valuation & earnings, CRVO or BGXX? CervoMed has higher revenue and earnings than Bright Green. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioCervoMed$7.14M1.71-$2.17MN/AN/ABright GreenN/AN/A-$13.13M-$0.06-1.21 Do analysts recommend CRVO or BGXX? CervoMed presently has a consensus target price of $42.00, indicating a potential upside of 2,024.00%. Given CervoMed's stronger consensus rating and higher possible upside, equities analysts plainly believe CervoMed is more favorable than Bright Green.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score CervoMed 1 Sell rating(s) 4 Hold rating(s) 3 Buy rating(s) 1 Strong Buy rating(s) 2.44Bright Green 0 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 0.00 Do institutionals & insiders hold more shares of CRVO or BGXX? 25.1% of CervoMed shares are held by institutional investors. Comparatively, 7.8% of Bright Green shares are held by institutional investors. 36.3% of CervoMed shares are held by company insiders. Comparatively, 62.5% of Bright Green shares are held by company insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a company is poised for long-term growth. Which has more risk and volatility, CRVO or BGXX? CervoMed has a beta of 1.62, meaning that its share price is 62% more volatile than the S&P 500. Comparatively, Bright Green has a beta of -0.48, meaning that its share price is 148% less volatile than the S&P 500. Is CRVO or BGXX more profitable? Bright Green has a net margin of 0.00% compared to CervoMed's net margin of -118.68%. CervoMed's return on equity of -44.11% beat Bright Green's return on equity.Company Net Margins Return on Equity Return on Assets CervoMed-118.68% -44.11% -39.81% Bright Green N/A -88.37%-55.30% SummaryCervoMed beats Bright Green on 13 of the 15 factors compared between the two stocks. Ad Diversified Trading InstituteCombine the QQQ, IWM and SPY in one tradeIf you’ve been investing in the major indexes for the last 20 years, you may need a new strategy. Because the Dow Jones has returned just 349%... The Russell 2000 has returned just 397%... And the S&P 500 has returned just 450%. And although I can’t guarantee results or against losses… I want to tell you about my “2-Click Trade” that has encapsulated more than the return of ALL THREE OF THOSE INDEXES COMBINED… Plus, it targets multiple overnight payouts in a month with 84.3% accuracy! While I cannot promise future returns or against losses…You can find out about this “2-Click Trade” here. Get Bright Green News Delivered to You Automatically Sign up to receive the latest news and ratings for BGXX and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart BGXX vs. The Competition Export to ExcelMetricBright GreenMedicinals & botanicals IndustryMedical SectorNASDAQ ExchangeMarket Cap$13.86M$397.78M$5.13B$9.28BDividend YieldN/AN/A4.81%4.06%P/E Ratio-1.2136.89135.2417.51Price / SalesN/A6.081,174.53134.92Price / CashN/A10.6640.4837.95Price / Book1.212.004.884.94Net Income-$13.13M-$51.46M$118.56M$225.30M7 Day PerformanceN/A-1.79%14.97%-1.11%1 Month PerformanceN/A-5.19%15.07%7.29%1 Year PerformanceN/A-3.95%34.31%23.06% Bright Green Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)BGXXBright GreenN/A$0.06-15.4%N/A-70.4%$11.49MN/A-1.002Gap DownCRVOCervoMed2.4983 of 5 stars$10.25-13.9%$48.63+374.4%-77.2%$63.24M$7.14M0.004Analyst DowngradeHigh Trading VolumeCNTBConnect Biopharma3.4498 of 5 stars$1.14+5.6%$8.00+601.8%+12.3%$62.99MN/A0.00110Short Interest ↓Gap UpSPROSpero Therapeutics4.6322 of 5 stars$1.14-2.6%$5.00+338.6%-19.8%$62.15M$103.78M16.7246AADIAadi Bioscience2.0716 of 5 stars$2.47+2.1%$1.67-32.5%+2.1%$60.89M$24.35M0.0040Short Interest ↓Positive NewsXCURExicure0.9447 of 5 stars$23.26-4.1%N/A+3,085.5%$60.71M$28.83M-10.5650CASICASI Pharmaceuticals4.2649 of 5 stars$3.89+7.2%$6.00+54.2%-50.7%$60.14M$33.88M0.00180Positive NewsGap UpSTTKShattuck Labs2.8054 of 5 stars$1.25flat$8.67+593.3%-82.6%$59.68M$1.66M-0.87100ALVRAlloVir1.1649 of 5 stars$0.51+2.0%N/A-80.7%$59.06MN/A0.00110IOBTIO Biotech3.4536 of 5 stars$0.88+2.0%$9.33+964.1%-46.3%$57.78MN/A0.0030Positive NewsPRLDPrelude Therapeutics1.969 of 5 stars$1.03+7.9%$4.75+361.2%-79.6%$56.68MN/A-0.60120Gap DownHigh Trading Volume Related Companies and Tools Related Companies CRVO Alternatives CNTB Alternatives SPRO Alternatives AADI Alternatives XCUR Alternatives CASI Alternatives STTK Alternatives ALVR Alternatives IOBT Alternatives PRLD Alternatives Top 10 Stock Comparisons Bank Stocks Artificial Intelligence Stocks Toy Stocks Growth Stocks Airline Stocks Chinese Stocks EV Charging Stocks Defense Stocks Lithium Stocks Pharmaceutical Stocks This page (NASDAQ:BGXX) was last updated on 12/18/2024 by MarketBeat.com Staff From Our PartnersUncover the Top Gold Stock of the Bull MarketGold Stocks Are Surging—Is West Red Lake Gold Mines Your Next Profit Play?Huge Alerts | SponsoredURGENT: This Altcoin Opportunity Won’t Wait – Act NowCrypto has officially entered the "banana zone" – that wild phase where prices can 1000x in days. It happen...Crypto Swap Profits | SponsoredMusk’s new company could top a trillion?The investment legend who predicted the rise of Bitcoin, Facebook and streaming services like Netflix… Just...Paradigm Press | SponsoredDo this Before Elon’s Reveal on January 22ndElon’s newest tech could pay you an extra $30,000 a year — while you sleep. It’s smaller than a quarter but...Brownstone Research | SponsoredPlease don’t take this warning lightly…Something huge is about to hit the stock market. Wall St. legend Louis Navellier calls it: "The most signif...InvestorPlace | SponsoredWhy Buffett, Griffin and 100 members of Congress are Piling into this One InvestmentThis isn't just another investment. It might be the last retirement stock you'll ever need. But this win...Behind the Markets | SponsoredDid You See Trump’s Bombshell Exec. Order 001?Starting with what I call Exec. Order 001. It’s a bombshell law that I believe Trump will sign within minut...Banyan Hill Publishing | SponsoredAI breakthrough about to upend industryEveryone is talking about AI right now. The talk has been endless ever since ChatGPT was released to the m...Porter & Company | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Bright Green Co. Please log in to your account or sign up in order to add this asset to your watchlist. Share Bright Green With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free BGXX Stock Alerts